Ventricular Dysfunction, Right

• 

  Subject Areas on Research

  • Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices. 
  • Biventricular pacing improves left ventricular function by 2-D strain in right ventricular failure. 
  • Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension. 
  • Branch Pulmonary Artery Valve Implantation Reduces Pulmonary Regurgitation and Improves Right Ventricular Size/Function in Patients With Large Right Ventricular Outflow Tracts. 
  • Cardiogenic shock. 
  • Clinical and echocardiographic predictors of mortality in acute pulmonary embolism. 
  • Comprehensive assessment of right ventricular function in patients with pulmonary hypertension with global longitudinal peak systolic strain derived from multiple right ventricular views. 
  • Controversies and Challenges of Ventricular Assist Device Therapy. 
  • Defibrillation causes immediate cardiac dilation in humans. 
  • Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device. 
  • Early effects of right ventricular volume overload on ventricular performance and beta-adrenergic signaling. 
  • Effects of cardiac glycosides on atrial contractile dysfunction after short-term atrial fibrillation. 
  • Effects of right ventricular morphology and function on outcomes of patients with degenerative mitral valve disease. 
  • Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. 
  • First-pass radionuclide angiography. 
  • Frequent Activation Delay-Induced Mechanical Dyssynchrony and Dysfunction in the Systemic Right Ventricle. 
  • Glenn shunt facilitated weaning of right ventricular mechanical support. 
  • Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension. 
  • Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. 
  • Hemodynamic findings in severe tricuspid regurgitation. 
  • Home surveillance program prevents interstage mortality after the Norwood procedure. 
  • Impact of initial shunt type on cardiac size and function in children with single right ventricle anomalies before the Fontan procedure: the single ventricle reconstruction extension trial. 
  • Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. 
  • Improving on the diagnostic characteristics of echocardiography for pulmonary hypertension. 
  • Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial. 
  • Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure. 
  • Myocardial beta-adrenergic receptor function and high-energy phosphates in brain death--related cardiac dysfunction. 
  • Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. 
  • Nasally Inhaled Nitric Oxide for Sudden Right-Sided Heart Failure in the Intensive Care Unit: NO Time Like the Present. 
  • Natriuretic peptide testing in clinical medicine. 
  • Normal myocardial function in severe right ventricular volume overload hypertrophy. 
  • Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. 
  • Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock. 
  • Persistent and reversible cardiac dysfunction among amateur marathon runners. 
  • Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. 
  • Pulmonary embolism: the diagnostic repertoire. 
  • RV instantaneous intraventricular diastolic pressure and velocity distributions in normal and volume overload awake dog disease models. 
  • Real-time three-dimensional echocardiography for determining right ventricular stroke volume in an animal model of chronic right ventricular volume overload. 
  • Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure. 
  • Relationships between cardiac magnetic resonance imaging abnormalities in the inter-ventricular septum and Selvester QRS scoring criteria for anterior-septal myocardial infarction in patients with right ventricular volume overload. 
  • Right Ventricular Function in Left Heart Disease. 
  • Right and left ventricular pressure overload as imaged by electrocardiogram. 
  • Right heart dilatation in adults: congenital causes. 
  • Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. 
  • Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. 
  • Right ventricular diastolic function in canine models of pressure overload, volume overload, and ischemia. 
  • Right ventricular diastolic relaxation in conscious dog models of pressure overload, volume overload, and ischemia. 
  • Right ventricular dissection diagnosed on transesophageal echocardiography. 
  • Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart. 
  • Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies. 
  • Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. 
  • Right ventricular echocardiographic indices predict poor outcomes in infants with persistent pulmonary hypertension of the newborn. 
  • Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. 
  • Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension. 
  • Right ventricular gene therapy with a beta-adrenergic receptor kinase inhibitor improves survival after pulmonary artery banding. 
  • Right ventricular hypertrophy with early dysfunction: A proteomics study in a neonatal model. 
  • Right ventricular injury in young swine: effects of catecholamines on right ventricular function and pulmonary vascular mechanics. 
  • Right ventricular targeted gene transfer of a beta-adrenergic receptor kinase inhibitor improves ventricular performance after pulmonary artery banding. 
  • Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function. 
  • Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. 
  • Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. 
  • Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. 
  • Staging classification of aortic stenosis based on the extent of cardiac damage. 
  • The Perfect Storm: Carcinoid Heart Disease and Acute Right Ventricular Failure. 
  • The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy. 
  • The forgotten chamber: the importance of the right ventricle. 
  • The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. 
  • The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. 
  • Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure. 
  • Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). 
  • Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device. 
• 

  Keywords of People

  • Karhausen, Jorn, Assistant Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology